Literature DB >> 27230226

Effect of Urea and Thiourea on Generation of Xenogeneic Extracellular Matrix Scaffolds for Tissue Engineering.

Maelene L Wong1,2, Janelle L Wong1, Rebecca M Horn1, Kimberley C Sannajust1, Dawn A Rice1, Leigh G Griffiths1.   

Abstract

Effective solubilization of proteins by chaotropes in proteomic applications motivates their use in solubilization-based antigen removal/decellularization strategies. A high urea concentration has previously been reported to significantly reduce lipophilic antigen content of bovine pericardium (BP); however, structure and function of the resultant extracellular matrix (ECM) scaffold were compromised. It has been recently demonstrated that in vivo ECM scaffold fate is determined by two primary outcome measures as follows: (1) sufficient reduction in antigen content to avoid graft-specific adaptive immune responses and (2) maintenance of native ECM structural proteins to avoid graft-specific innate responses. In this work, we assessed residual antigenicity, ECM architecture, ECM content, thermal stability, and tensile properties of BP subjected to a gradient of urea concentrations to determine whether an intermediate concentration exists at which both antigenicity and structure-function primary outcome measures for successful in vivo scaffold outcome can simultaneously be achieved. Alteration in tissue structure-function properties at various urea concentrations with decreased effectiveness for antigen removal makes use of urea-mediated antigen removal unlikely to be suitable for functional scaffold generation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27230226      PMCID: PMC4943467          DOI: 10.1089/ten.TEC.2015.0552

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  25 in total

1.  Optimization of a method for preparation and repopulation of the tracheal matrix for allogenic transplantation.

Authors:  M V Kiselevsky; N Yu Anisimova; O V Lebedinskaya; B E Polotskii; M I Davydov
Journal:  Bull Exp Biol Med       Date:  2011-05       Impact factor: 0.804

2.  The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering.

Authors:  Maelene L Wong; J Kent Leach; Kyriacos A Athanasiou; Leigh G Griffiths
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

3.  Mass transfer trends occurring in engineered ex vivo tissue scaffolds.

Authors:  Marc Moore; Malisa Sarntinoranont; Peter McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

4.  Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.

Authors:  Hong-Gook Lim; Gi Beom Kim; Saeromi Jeong; Yong Jin Kim
Journal:  Eur J Cardiothorac Surg       Date:  2014-10-14       Impact factor: 4.191

5.  Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults.

Authors:  Chun Soo Park; Sam-Se Oh; Young Eun Kim; Sun Young Choi; Hong-Gook Lim; Hyuk Ahn; Yong Jin Kim
Journal:  J Heart Valve Dis       Date:  2013-03

6.  Scaffold with a natural mesh-like architecture: isolation, structural, and in vitro characterization.

Authors:  Krishna Burugapalli; Anilkumar Thapasimuttu; Jeffrey C Y Chan; Li Yao; Sarah Brody; Jack L Kelly; Abhay Pandit
Journal:  Biomacromolecules       Date:  2007-02-20       Impact factor: 6.988

7.  Stepwise solubilization-based antigen removal for xenogeneic scaffold generation in tissue engineering.

Authors:  Maelene L Wong; Janelle L Wong; Kyriacos A Athanasiou; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2013-01-12       Impact factor: 8.947

Review 8.  Sequential extraction of proteins by chemical reagents.

Authors:  Stuart J Cordwell
Journal:  Methods Mol Biol       Date:  2008

9.  In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.

Authors:  Maelene L Wong; Janelle L Wong; Natalia Vapniarsky; Leigh G Griffiths
Journal:  Biomaterials       Date:  2016-03-19       Impact factor: 12.479

10.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients.

Authors:  P Simon; M T Kasimir; G Seebacher; G Weigel; R Ullrich; U Salzer-Muhar; E Rieder; E Wolner
Journal:  Eur J Cardiothorac Surg       Date:  2003-06       Impact factor: 4.191

View more
  6 in total

Review 1.  Preparation and Characterization of Human Adipose Tissue-Derived Extracellular Matrix, Growth Factors, and Stem Cells: A Concise Review.

Authors:  So Young Chun; Jeong Ok Lim; Bongsu Jung; Tae Gyun Kwon; Eun Hye Lee; Man-Hoon Han; Yun-Sok Ha; Jun Nyung Lee; Bum Soo Kim; Min Jeong Park; MyungGu Yeo
Journal:  Tissue Eng Regen Med       Date:  2019-07-05       Impact factor: 4.169

2.  Magnesium Presence Prevents Removal of Antigenic Nuclear-Associated Proteins from Bovine Pericardium for Heart Valve Engineering.

Authors:  Ailsa J Dalgliesh; Zhi Zhao Liu; Leigh G Griffiths
Journal:  Tissue Eng Part A       Date:  2017-03-10       Impact factor: 3.845

Review 3.  Decellularization for the retention of tissue niches.

Authors:  Deana Moffat; Kaiming Ye; Sha Jin
Journal:  J Tissue Eng       Date:  2022-05-21       Impact factor: 7.940

4.  Developing a pro-angiogenic placenta derived amniochorionic scaffold with two exposed basement membranes as substrates for cultivating endothelial cells.

Authors:  Siavash Shariatzadeh; Sepehr Shafiee; Ali Zafari; Tahereh Tayebi; Ghasem Yazdanpanah; Alireza Majd; Arvin Haj-Mirzaian; Soheyl Bahrami; Hassan Niknejad
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

Review 5.  Decellularized blood vessel development: Current state-of-the-art and future directions.

Authors:  Xinyu Wang; Vincent Chan; Peter R Corridon
Journal:  Front Bioeng Biotechnol       Date:  2022-08-08

6.  Decellularization and Solubilization of Porcine Liver for Use as a Substrate for Porcine Hepatocyte Culture: Method Optimization and Comparison.

Authors:  Ramon E Coronado; Maria Somaraki-Cormier; Shanmugasundaram Natesan; Robert J Christy; Joo L Ong; Glenn A Halff
Journal:  Cell Transplant       Date:  2017-12       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.